**Latest issues can only be accessed via our mailing list. Join now to stay up to date**

In this issue:

  • NICE updates: ruxolitinib and glycopyrronium cream

  • LDOM in paediatric patients

  • A Delphi consensus on chronic prurigo

  • A systematic review of dupilumab-associated facial and neck erythema

  • Zinc deficiency in bullous pemphigoid

  • Determinants of real-world sunscreen effectiveness

  • Does gamification improve training?

  • Ruxolitinib ‘super responders’ in vitiligo treatment

  • Oestrogen therapy for menopausal hair loss?

  • European SCC guidelines

Oct 2026 issue